Skip to main content
. 2016 Oct 28;11(12):2123–2131. doi: 10.2215/CJN.05170516

Figure 4.

Figure 4.

Differing ninety-day mortality rates associated with incident AKI electronic alerts for clinical location of AKI subsets. (A) Percentage of patients with AKI who died divided according to place of identification of AKI. (B) Percentage of patients with community-acquired AKI (CA-AKI) who died divided according to hospitalization. (C) Percentage of patients with CA-AKI who died divided according to place of identification of AKI. Mortality was significantly higher for all of the admitted groups (P<0.001 compared with nonadmitted groups). Mortality rates were comparable in the admitted nonprimary care CA-AKI and hospital-acquired AKI (HA-AKI) groups, which were significantly higher than in the primary care AKI (PC-AKI) admitted cohort (P<0.01). Numbers of patients with data available are indicated in parentheses on the x axis. Shading indicates the proportion of patients who died by AKI stage. Hosp. CA-AKI, hospitalized community–acquired AKI; non-hosp. CA-AKI, nonhospitalized community–acquired AKI; non–PC-AKI, nonprimary care AKI.